<DOC>
	<DOCNO>NCT01232439</DOCNO>
	<brief_summary>To measure occupancy brain kappa opioid receptor single oral dos LY2456302 .</brief_summary>
	<brief_title>A Study Brain Receptor Occupancy Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Healthy male female Have clinical laboratory test within normal reference range Have arterial venous access sufficient allow blood sample Currently enrol , discontinue within last 30 day clinical trial History severe allergy multiple adverse drug reaction Have abnormal ECG screen visit Have abnormal sit blood pressure Have increase risk seizure Current suicidal ideation Positive test HIV , hepatitis C , hepatitis B Women breast feed Smoke 10 cigarette per day , equivalent Drink 5 cup coffee per day , equivalent Have history head injury Unable undergo MRI Suffer claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>